<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microsatellite instability (MSI) due to mismatch repair (MMR) deficiency is reported in 5-10% of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) complicating <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e> (IBD) </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular mechanisms underlying MMR deficiency may be different in IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, and in <z:hpo ids='HP_0003745'>sporadic</z:hpo> and hereditary MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we hypothesize that overexpression of miR-155 and miR-21, two <z:mp ids='MP_0001845'>inflammation</z:mp>-related microRNAs that target core MMR proteins, may constitute a pre-neoplastic event for the development of MSI IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We studied miR-155 and miR-21 expression using real-time quantitative PCR in MSI (n = 10) and microsatellite stable (n = 10) IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, and in MSI (n = 32) and microsatellite stable (n = 30) non-IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We also screened colonic samples from IBD patients without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (n = 18) and used healthy colonic mucosa as controls (n = 20) </plain></SENT>
<SENT sid="5" pm="."><plain>MiR-155 and miR-21 appeared significantly overexpressed not only in the colonic mucosa of IBD subjects without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> but also in neoplastic tissues of IBD patients compared with non-IBD controls (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, in patients with IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, miR-155 and miR-21 overexpression extended to the distant non-neoplastic mucosa (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Ratios of expressions in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> versus matched distant mucosa revealed a nearly significant association between miR-155 overexpression and MSI in IBDs (P = 0.057) </plain></SENT>
<SENT sid="8" pm="."><plain>These results show a strong deregulation of both MMR-targeting microRNAs in IBD subjects with or without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>MiR-155 overexpression being particularly associated to MSI IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and extending to distant non-neoplastic mucosa, strongly suggests that a pre-neoplastic miR-155 field defect may promote MSI-driven transformation of the colonic mucosa </plain></SENT>
<SENT sid="10" pm="."><plain>The detection and monitoring of miR-155 field defect may, therefore, have implications for the prevention and treatment of MSI IBD <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
</text></document>